Abstract:
|
Title III of the 21st Century Cures Act defines and discusses "patient experience data". At this roundtable, we will talk about several types of patient experience data including clinical outcome assessment (COA) data from various studies, patient-focused drug development or other meeting summary reports, plus data from qualitative, natural history, patient preference, and observational survey studies. We will discuss various methods that might be used to collect these types of data, potential analysis methods that might be used and interpretations.
|